If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
120.50    1.50 (1.26%)
Bid:
119.00
Ask:
120.00
Spread: 1.00 (0.84%)
Market Cap: £94.56m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Trading Update

3 Aug 2023 07:00

RNS Number : 0903I
Xaar PLC
03 August 2023
 

3 August 2023

 

Xaar plc

 

TRADING UPDATE

 

Xaar plc ("Xaar" or "the Group"), the leading inkjet printing technology group, today announces a trading update for the six months ended 30 June 2023.

 

TRADING

 

Continued strong trading - in line with expectations

 

· Revenue for the period anticipated to be £34.7 million (H1 2022: £36.6 million).

· Adjusted profit before tax in line with management expectations, with the impact of the successful factory re-organisation offset by the planned sale of £1.8 million of non-core IP assets.

 

Further strategic and operational progress

 

· Increasing number of customers developing products using Aquinox with product launches expected in H2 2023.

· Commercial partnership with Quantica announced on 5 July 2023 enhances the Group's position in leading the market in printing highly viscous fluids.

· Phase one of factory efficiency programme completed on time and within budget.

· Product Print Systems business ("EPS") delivered a strong performance in the period with both revenue and margin growth.

 

 

BALANCE SHEET

 

The Group remains well capitalised with a strong balance sheet and with a net cash position as at 30 June 2023 of £7.3 million (30 June 2022: £12.6 million) in line with management expectations, reflecting the previously communicated investment in inventory predominantly in H2 2022.

 

 

OUTLOOK

 

· Market conditions expected to improve further in China in H2 and coupled with increased customer product launches will increase demand for Xaar printheads.

· Our strategy to diversify across a range of market sectors means further product launches are expected in 2024 providing confidence in delivering our mid-term growth plans.

· Previous investment in inventory holding means the Group is well placed to capitalise on further commercial opportunities.

· While remaining vigilant to broader macroeconomic conditions the Board continues to expect to deliver its expectations for the full year.

 

 

John Mills, Chief Executive Officer, commented:

 

"We remain focused on the delivery of our strategy and taking advantage of the significant opportunities we have that will drive profitable growth. Our products continue to generate strong interest from customers, demonstrating our leadership in printing highly viscous fluids with all the sustainability benefits they can deliver. We have positive momentum, a growing product pipeline and look forward to continuing to accelerate our strategy and performance in H2 and into 2024."

 

 

 

Note: Adjusted profit before tax is profit before tax excluding the impact of share-based payment charges, exchange differences relating to intra-group transactions, gain on derivative financial instruments, restructuring and transaction expenses, research and development expenditure credit, fair value gain on financial assets at fair value through profit and loss, and amortisation of acquired intangible assets.

 

 

Enquiries:

 

Xaar plc

+44 (0) 1223 423 663 

Ian Tichias, Chief Financial Officer

John Mills, Chief Executive Officer

Teneo

+44 (0) 207 353 4200

Giles Kernick

Olivia Lucas

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKBBBDBKDPFK
Date   Source Headline
1st May 20192:21 pmRNSTotal Voting Rights
1st May 201910:15 amRNSGrant of Options
30th Apr 20192:59 pmRNSHolding(s) in Company
2nd Apr 201910:31 amRNSTotal Voting Rights
21st Mar 20197:00 amRNSXaar plc 2018 Full Year Results
11th Mar 20197:00 amRNSTrading Update
1st Mar 20199:53 amRNSTotal Voting Rights
1st Feb 20191:12 pmRNSTotal Voting Rights
2nd Jan 20194:48 pmRNSBlock Listing Six Monthly Return
2nd Jan 20194:45 pmRNSTotal Voting Rights
2nd Jan 201912:07 pmRNSSecond Price Monitoring Extn
2nd Jan 201912:02 pmRNSPrice Monitoring Extension
28th Dec 20187:00 amRNSTrading Update
3rd Dec 20184:12 pmRNSTotal Voting Rights
20th Nov 20187:00 amRNSNEOS AND KELENN TECHNOLOGY ADOPT XAAR 5601
5th Nov 201811:12 amRNSHolding(s) in Company
1st Nov 20183:21 pmRNSTotal Voting Rights
24th Oct 20187:00 amRNSAppointment of CFO and Company Secretary
11th Oct 201812:07 pmRNSSecond Price Monitoring Extn
11th Oct 201812:02 pmRNSPrice Monitoring Extension
10th Oct 201812:07 pmRNSSecond Price Monitoring Extn
10th Oct 201812:02 pmRNSPrice Monitoring Extension
1st Oct 20185:20 pmRNSTotal Voting Rights
5th Sep 20187:00 amRNSW&H Chooses Xaar 5601
5th Sep 20187:00 amRNSXaar 2018 Interim Results
4th Sep 20188:30 amRNSTotal Voting Rights
4th Sep 20188:05 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSTrading Update
1st Aug 20182:40 pmRNSTotal Voting Rights
12th Jul 20187:00 amRNSAnnouncement of 3D Printing Joint Investment
2nd Jul 20185:39 pmRNSBlock listing Interim Review
2nd Jul 20185:37 pmRNSTotal Voting Rights
27th Jun 20187:00 amRNSTrading Statement
1st Jun 20182:25 pmRNSTotal Voting Rights
30th May 20187:00 amRNSBoard Change
22nd May 201812:12 pmRNSResult of AGM
1st May 20185:02 pmRNSTotal Voting Rights
11th Apr 201812:02 pmRNSPrice Monitoring Extension
5th Apr 20189:38 amRNSGrant of Options
3rd Apr 201812:26 pmRNSTotal Voting Rights
3rd Apr 201810:54 amRNSBoard Change
23rd Mar 20182:10 pmRNSHolding(s) in Company
21st Mar 20187:00 amRNSXaar plc 2017 Full Year Results
20th Mar 20181:25 pmRNSHolding(s) in Company
12th Mar 201810:58 amRNSHolding(s) in Company
1st Mar 20183:57 pmRNSTotal Voting Rights
2nd Feb 20188:00 amRNSNotice of Scheduled Results
1st Feb 201811:11 amRNSTotal Voting Rights
5th Jan 20187:00 amRNSBlock listing Interim Review
5th Jan 20187:00 amRNSIssue of Equity - Share Scheme and Block Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.